BioGaia
126 SEK +1.04%2 investors are following this company
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Revenue
-
EBIT %
-
P/E
34.81
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOG B
Daily low / high price
123.4 / 127.5
SEK
Market cap
12.72B SEK
Turnover
5.64M SEK
Volume
45K
Latest videos
Financial calendar
Interim report
2024-10-22
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
EQT | 11.1 % | 8.3 % |
Fjärde AP-fonden | 7.7 % | 5.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
BioGaia AB: Interim Management Statement January - June 2024
BioGaia AB: Delårsredogörelse januari - juni 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools